IQVIA to be a Premier Sponsor of ACDM22
Date: August 19, 2021
The Association for Clinical Data Management is delighted to announce that IQVIA are to be a Premier Sponsor of ACDM22.
IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry. Powered by the IQVIA CORE™, IQVIA delivers unique and actionable insights at the intersection of large-scale analytics, transformative technology and extensive domain expertise, as well as execution capabilities. Formed through the merger of IMS Health and Quintiles, IQVIA has approximately 68,000 employees worldwide.
ACDM22 is the 2022 Annual Conference of the Association for Clinical Data Management and is being held in Edinburgh, Scotland, from the 13th-15th March 2022.
Explore More News

HMA/EMA joint Big Data Steering Group: Big Data Workplan 2023-2025
The joint HMA-EMA Big Data Steering Group (BDSG) have released their latest workplan, . . .
Read More

ACT EU PA04 – Multi-stakeholder Workshop on ICH E6 R3
As part of the Accelerating Clinical Trials in the EU (ACT EU) multi-annual workplan . . .
Read More

European Medicine’s Agency – Reflection paper on the use of artificial intelligence in the lifecycle of medicines
The EMA has opened a public consultation on a reflection paper presenting views . . .
Read More

Welcome Instem as a new corporate member
The ACDM: Association for Clinical Data Management is delighted to welcome Instem as a new . . .
Read More

Regulatory Considerations Expert Group reviews draft FDA Guidance
The ACDM Regulatory Considerations Expert Group have reviewed and submitted comments on . . .
Read More

ICH GCP E6 Revision 3 is here. Regulatory Considerations Expert Group to review
The R&D industry, especially those that are working on clinical trials, have been . . .
Read More

Welcome Algorics as a new corporate member
The ACDM: Association for Clinical Data Management is delighted to welcome Algorics as a . . .
Read More

Consultation response on legislative proposals for clinical trials
The MHRA have published the public consultation response to the proposals to reform the . . .
Read More

New MHRA Guidance
The MHRA have published new guidance on ‘Software and Artificial Intelligence (AI) as a . . .
Read More

FDA Guidance for Industry
The FDA has issued a final guidance to provide information on risk-based approaches to . . .
Read More

Guideline on computerised systems and electronic data in clinical trials
The European Medicines Agency (EMA) have published the new guidelines on computerised . . .
Read More

Welcome IROS – Insights Research Organization & Solutions as a new corporate member
The ACDM: Association for Clinical Data Management is delighted to welcome IROS – Insights . . .
Read More